Oral Formulation For The Treatment Of Cardiovascular Diseases

Patent No. EP2986281 (titled "Oral Formulation For The Treatment Of Cardiovascular Diseases") was filed by Ferrer Internacional on Jun 5, 2014. The application was issued on Dec 21, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GALENICUM HEALTH SLUSep 21, 2017TORREJON NIETO

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2986281

FERRER INTERNACIONAL
Application Number
EP14728940A
Filing Date
Jun 5, 2014
Status
Opposition Rejected
Jul 26, 2019
Publication Date
Dec 21, 2016